NZM2:ETR
Novozymes A/S
58,00 €
0,00%
(0,00) 1D
9 tet, 5:35:30 m.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për NZM2...
Hap
57,64 €
I lartë
58,10 €
I ulët
57,64 €
Kapitalizimi i tregut
180,41 mld
Vëllimi mesatar
120,00
Vëllimi
5,00
Maksimumi 52-javor
61,96 €
Minimumi 52-javor
46,74 €
Numri i punonjësve
11 mijë
Hap
57,64 €
I lartë
58,10 €
I ulët
57,64 €
Kapitalizimi i tregut
180,41 mld
Vëllimi mesatar
120,00
Vëllimi
5,00
Maksimumi 52-javor
61,96 €
Minimumi 52-javor
46,74 €
Numri i punonjësve
11 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Seeking Alpha
·
22 minuta më parë
15 Years In, I've Never Seen The S&P 500 Hide So Much Damage
Simply Wall Street
·
1 orë më parë
Low Valuation Could Change The Case For APA Stock (APA)
Forbes
·
52 minuta më parë
Stock Market Crash Hits 54% Of Stocks—Is The S&P 500 Next?
Profili
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
Rreth Novozymes A/S
Drejtori ekzekutivEster Baiget
Punonjësit11,1 mijë
Themeluar më2000
Selia-
SektoriSpeciality chemicals
Uebsajtinovonesis.com